Patent ID: 9586992
Date: 2017-03-07
CPC Classifications: A61K,A61P,C07K

Claim:
1. A method for promoting the survival and/or function of dopaminergic neurons, comprising administering to a subject in need thereof a pharmaceutically effective amount of a composition comprising at least one of the following peptides: (a) a purified Amidated Dopamine Neuron Stimulating peptide (ADNS peptide) comprising the amino acid sequence ERNRQAAAANPENSRGK-amide (SEQ ID NO: 2); (b) a purified ADNS peptide comprising the amino acid sequence FPLPA-amide (SEQ ID NO: 3); and (c) a purified ADNS peptide comprising the amino acid sequence PPEAPAEDRSL-amide (SEQ ID NO: 4) wherein the composition is administered to a subject having at least one condition selected from the group consisting of Parkinson's Disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); and wherein the composition is administered in an amount sufficient to increase the level of at least one of dopamine and a dopamine metabolite in the subject.